Patient P-02498

Synthetic patientMETA-24 · Day 99 · 25–34 · F · baseline S06Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Favorable

GI state

Favorable

Inflammatory state

Deteriorating

Nutritional resilience

Improving

Discontinuation risk

15%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S06

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Inflammatory activity+6
Nutritional resilience+6
GI instability+2
Treatment adherence-2
Toxicity+2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

43 min

stable · +1.4 vs previous 14 d

Sleep duration

Wearable

6.3 h

stable · -0.0 vs previous 14 d

Energy level

Daily log

6.9/10

stable · -0.1 vs previous 14 d

Steps

Wearable

4,311

worsening · -274 vs previous 14 d

GI burden

Companion

19.1/100

worsening · +1.8 vs previous 14 d

Adherence

Companion

89.9 %

stable · -2.8 vs previous 14 d

Sleep quality

Wearable

42.7/100

worsening · -3.3 vs previous 14 d

Glucose, CGM daily mean

CGM

129 mg/dL

stable · +2.3 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 87 from the failing basin, 5 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -3.8 next day on high-intake days · n 25

Would not help

Keep caffeine low
GI +3.7 next day on high-intake days · n 18
Keep alcohol low
GI +3.5 next day on high-intake days · n 15

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-3.8supporter · 95%
Caffeine
+3.7detractor · 95%
Alcohol
+3.5detractor · 90%
Simple carbohydrates
+2.8no signal · 52%
Ultra-processed food
-1.8no signal · 43%
Insoluble fibre
+0.7no signal · 17%
Histamine load
+0.4no signal · 15%
Dietary fat load
0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
Autonomic recovery ↓20
- WearableShort sleep window

DNA

Fictional pharmacogenomic panel

CYP2D6 Poor metabolizer
Higher exposure at standard dose

Microbiome

Shannon diversity 3.5 · butyrate capacity 46/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 65 ms
Sleep: 6.3 h
Steps: 5,011
Resting HR: 65 bpm

Daily log: GI score 19, nutritional resilience 70, adherence 90.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02555	53%	S01	AD-05	no change	79
P-02277	47%	S05	AD-05	improved	92
P-02282	46%	S01	BR-03	no change	88
P-02013	39%	S14	BR-03	no change	94
P-02280	30%	S07	BR-03	no change	50
P-02193	42%	S11	CR-01	improved	87
P-02354	31%	S01	CR-01	improved	78
P-02565	46%	S09	DT-01	no change	79
P-02081	45%	S20	DT-01	no change	88
P-02337	41%	S18	DT-01	no change	100
P-02249	40%	S09	DT-01	improved	100
P-02462	32%	S12	DT-01	improved	65